In Vivo Dissolution of Nanoceria during Catalytic Workout
Lena Montaña a, Neus Bastus b, Laura Mondragon b, Dmitry Galyamin c, Neus Sabate c, Victor Puntes a b
a Vall Hebron Institut Recerca, Passeig de la Vall d'Hebron, Barcelona, Spain
b Institut Català de Nanociència i Nanotecnologia (ICN2), Campus de la Universitat Autònoma de Barcelona (Campus UAB), 08193, Bellaterra, Barcelona, Spain
c IMN-Instituto de Micro y Nanotecnología (CNM-CSIC), 28760 Tres Cantos, Madrid, España, Tres Cantos, Spain
Proceedings of Internet NanoGe Conference on Nanocrystals (iNCNC)
Online, Spain, 2021 June 28th - July 2nd
Organizers: Maksym Kovalenko, Maria Ibáñez, Peter Reiss and Quinten Akkerman
Poster, Lena Montaña, 063
Publication date: 8th June 2021
ePoster: 

Nanoceria (Cerium Oxide Nanoparticles) is one of the main compounds among the useful materials of the rare-earth elements. The crystal structure of these nanoparticles make them ideal electron scavengers, and there are many processes where nanoceria are used as catalyst or active support and oxygen buffers. The ability to switch valence states between Ce3+ and Ce4+ depending on the surroundings, also in physiological conditions, makes nanoceria a striking material for biomedecine, especially in the modulation of oxidative stress in living organisms. Plenty of reports are constantly appearing praising the wide spectrum antioxidant enzyme-mimetic activities and immunomodulatory properties of nanoceria to develop new treatments for many diseases ranging from retinal degeneration, neurodegenerative diseases, diabetes, ischemia, cardiopathies, gastrointestinal inflammation, liver fibrosis, and cancer.[1] It is attracting more and more attention in the research community in bio- nano- medicine. For these reason, there is a need to study nanoceria safety in biologic systems. Here we present a possible nanoparticle (NP) degradation mechanism when nanoceria is exposed to Reactive Oxygen Species (ROS) and therefore, during its catalytic cycle. Nanoceria oxidation state is studied mediating UV-vis spectroscopy. Finally, biodistribution of nanoceria (≈2.5 nm) administered intravenously (IV) to mice is reported.

© FUNDACIO DE LA COMUNITAT VALENCIANA SCITO
We use our own and third party cookies for analysing and measuring usage of our website to improve our services. If you continue browsing, we consider accepting its use. You can check our Cookies Policy in which you will also find how to configure your web browser for the use of cookies. More info